{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:15:50Z","timestamp":1781630150702,"version":"3.54.5"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>In this systematic review, we aimed to investigate the efficacy and safety of adding low-molecular-weight heparin (LMWH) or unfractionated heparin to low-dose aspirin (LDA) started \u226416 weeks'gestation in the prevention of preeclampsia (PE) in high-risk women.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>PubMed, Cochrane Library, Embase, and <jats:ext-link>ClinicalTrials.gov<\/jats:ext-link> databases were searched from their inception to April 2022 for randomized controlled trials (RCTs) that to determine whether the combined treatment of LMWH and LDA is better than single anticoagulant drugs in preventing PE and improving live birth rate of fetus in high-risk women with pregnancy \u226416 weeks. We also searched Embase, OVID MEDLINE and OVID MEDLINE in-process using the OVID platform.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>14 RCTs involving 1,966 women were found. The LMWH (or unfractionated heparin) and LDA groups included 1,165 wemen, and the LDA group included 960 women. The meta-analysis showed that the addition of LMWH to LDA reduced the risk of PE (RR: 0.59, 95% CI: 0.44-0.79, <jats:italic>P<\/jats:italic> &amp;lt; <jats:italic>0.05<\/jats:italic>), small-for-gestational age (SGA, RR: 0.71, 95% CI: 0.52-0.97, <jats:italic>P<\/jats:italic> = <jats:italic>0.03<\/jats:italic>), fetal and neonatal death (RR: 0.45, 95% CI: 0.23-0.88, <jats:italic>P<\/jats:italic> = <jats:italic>0.02<\/jats:italic>) and gestational hypertension (RR: 0.47, 95% CI: 0.25-0.90, <jats:italic>P<\/jats:italic> = <jats:italic>0.02<\/jats:italic>). It is worth emphasizing that LMWH (or unfractionated heparin) combined with LDA did not increase the risk of bleeding.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>LMWH combined with LDA can effectively improve the pregnancy outcome of women with high risk factors for PE and its complications. Although this study showed that combined medication also did not increase the risk of bleeding, but such results lack the support of large sample size studies. The clinical safety analysis of LMWH combined with LDA in patients with PE should be more carried out.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.1073148","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T06:45:12Z","timestamp":1670568312000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Low-molecular-weight heparin in addition to low-dose aspirin for preventing preeclampsia and its complications: A systematic review and meta-analysis"],"prefix":"10.3389","volume":"9","author":[{"given":"Li","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.semperi.2011.09.011","article-title":"Maternal mortality from preeclampsia\/eclampsia","volume":"36","author":"Ghulmiyyah","year":"2012","journal-title":"Semin Perinatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ajog.2010.08.009","article-title":"The \u201cgreat obstetrical syndromes\u201d are associated with disorders of deep placentation","volume":"204","author":"Brosens","year":"2011","journal-title":"Am J Obstet Gynecol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1177\/1076029615615972","article-title":"The role of anticoagulants in the prevention of pregnancy complications","volume":"23","author":"Leaf","year":"2017","journal-title":"Clin Appl Thromb Hemost."},{"key":"B4","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.placenta.2005.12.006","article-title":"The uterine spiral arteries in human pregnancy: facts and controversies","volume":"27","author":"Pijnenborg","year":"2006","journal-title":"Placenta"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1126\/science.1111726","article-title":"Latest advances in understanding preeclampsia","volume":"308","author":"Redman","year":"2005","journal-title":"Science."},{"key":"B6","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","article-title":"Pre-eclampsia","volume":"387","author":"Steegers","year":"2016","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1053\/plac.2002.0930","article-title":"Pre-eclampsia, the placenta and the maternal systemic inflammatory response\u2013a review","volume":"24","author":"Redman","year":"2003","journal-title":"Placenta"},{"key":"B8","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1002\/uog.15789","article-title":"Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis","volume":"47","author":"Roberge","year":"2016","journal-title":"Ultrasound Obstet Gynecol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.3892\/etm.2018.5972","article-title":"Low-dose aspirin at \u2264 16 weeks of gestation for preventing preeclampsia and its maternal and neonatal adverse outcomes: a systematic review and meta-analysis","volume":"15","author":"Cui","year":"2018","journal-title":"Exp Ther Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1161\/HYPERTENSIONAHA.116.08298","article-title":"Low molecular weight heparin improves endothelial function in pregnant women at high risk of preeclampsia","volume":"69","author":"McLaughlin","year":"2017","journal-title":"Hypertension."},{"key":"B11","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1182\/blood-2013-01-478958","article-title":"Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications","volume":"123","author":"Rodger","year":"2014","journal-title":"Blood"},{"key":"B12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11239-006-5578-5","article-title":"Anticoagulants in pregnancy","volume":"21","author":"Greer","year":"2006","journal-title":"J Thromb Thrombolysis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1097\/AOG.0000000000003892","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/uog.22134","article-title":"ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction","volume":"56","author":"Lees","year":"2020","journal-title":"Ultrasound Obstet Gynecol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ."},{"key":"B17","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions\n            HigginsJP\n            ThomasJ\n            ChandlerJ\n            CumpstonM\n            LiT\n            PageMJ\n          35352103John Wiley & Sons2021"},{"key":"B18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1080\/14767058.2019.1671348","article-title":"Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation","volume":"33","author":"Karadag","year":"2020","journal-title":"J Matern Fetal Neonatal Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1186\/s12884-016-1162-y","article-title":"Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a prior history - an open-label randomized trial (the EPPI trial): study protocol","volume":"16","author":"Groom","year":"2016","journal-title":"BMC Pregnancy Childbirth."},{"key":"B21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ejogrb.2015.12.011","article-title":"Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT","volume":"197","author":"van van Hoorn","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1097\/AOG.0000000000001673","article-title":"Enoxaparin and aspirin compared with aspirin alone to prevent placenta-mediated pregnancy complications: a randomized controlled trial","volume":"128","author":"Haddad","year":"2016","journal-title":"Obstet Gynecol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3899\/jrheum.080763","article-title":"Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepLDA trial","volume":"36","author":"Laskin","year":"2009","journal-title":"J Rheumatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1756-0500-7-23","article-title":"Low dose aspirin and low-molecular-weight heparin in the treatment of pregnant Libyan women with recurrent miscarriage","volume":"7","author":"Elmahashi","year":"2014","journal-title":"BMC Res Notes"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1160\/TH11-05-0340","article-title":"Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomised controlled NOH-PE trial","volume":"106","author":"Gris","year":"2011","journal-title":"Thromb Haemost."},{"key":"B26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/j.1538-7836.2011.04553.x","article-title":"Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT","volume":"10","author":"de Vries","year":"2012","journal-title":"J Thromb Haemost."},{"key":"B27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1160\/TH10-05-0334","article-title":"Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial","volume":"105","author":"Visser","year":"2011","journal-title":"Thromb Haemost."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1056\/NEJMoa1000641","article-title":"Aspirin plus heparin or aspirin alone in women with recurrent miscarriage","volume":"362","author":"Kaandorp","year":"2010","journal-title":"N Engl J Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1160\/TH10-03-0167","article-title":"Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae. The pilot randomised controlled NOH-AP trial","volume":"104","author":"Gris","year":"2010","journal-title":"Thromb Haemost."},{"key":"B30","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/10641950600745517","article-title":"Prophylaxis of recurrent preeclampsia: low-molecular-weight heparin plus low-dose aspirin versus low-dose aspirin alone","volume":"25","author":"Sergio","year":"2006","journal-title":"Hypertens Pregnancy."},{"key":"B31","first-page":"CR132","article-title":"The role of aspirin versus aspirin and heparin in cases of recurrent abortions with raised anticardiolipin antibodies","volume":"12","author":"Goel","year":"2006","journal-title":"Med Sci Monit."},{"key":"B32","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/00006250-200212000-00032","article-title":"Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment","volume":"100","author":"Farquharson","year":"2002","journal-title":"Obstet Gynecol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1053\/j.semperi.2007.05.002","article-title":"Adverse pregnancy outcome, the uteroplacental interface, and preventive strategies","volume":"31","author":"Hossain","year":"2007","journal-title":"Semin Perinatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.placenta.2010.11.023","article-title":"Placental and trophoblastic in vitro models to study preventive and therapeutic agents for preeclampsia","volume":"32","author":"Orendi","year":"2011","journal-title":"Placenta"},{"key":"B35","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/MJT.0b013e318164bd60","article-title":"Nitric oxide and aspirin: a new mediator for an old drug","volume":"16","author":"Schr\u00f6der","year":"2009","journal-title":"Am J Ther"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"743: low-dose aspirin use during pregnancy","volume":"132","year":"2018","journal-title":"Obstet Gynecol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1160\/TH14-10-0848","article-title":"The physiologic anticoagulant and anti-inflammatory role of heparins and their utility in the prevention of pregnancy complications","volume":"113","author":"Mastrolia","year":"2015","journal-title":"Thromb Haemost."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/humrep\/dex069","article-title":"Enhancement of trophoblast differentiation and survival by low molecular weight heparin requires heparin-binding EGF-like growth factor","volume":"32","author":"Bolnick","year":"2017","journal-title":"Hum Reprod"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1097\/AOG.0b013e31823234ad","article-title":"Aspirin and heparin effect on bLDAl and antiphospholipid antibody modulation of trophoblast function","volume":"118","author":"Han","year":"2011","journal-title":"Obstet Gynecol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3760\/cma.j.cn112141-20200114-00039","article-title":"Guidelines for the diagnosis and treatment of pregnancy induced hypertension","volume":"55","year":"2020","journal-title":"Chin J Obst Gynecol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1073148\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T06:45:16Z","timestamp":1670568316000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1073148\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":40,"alternative-id":["10.3389\/fcvm.2022.1073148"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.1073148","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,9]]},"article-number":"1073148"}}